Construisons dans un monde qui bouge. CIC is the fourth largest banking group in France, consisting of seven regional banks which operate across France through a network of 1,844 branches employing 24,000 staff. CIC's customer base includes 2.7 million retail clients. One in eleven self-employed professionals is a CIC group client and nearly one in three companies banks with CIC Group. Banque de détail, Banque de financement, Activités de marchés, Banque privée, Capital-développement, Crédit, Assurance, Mobile, Automobile, and Télésurveillance

Sectors: Bank

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical

[Automatic translation follows] Collective movement committed to the influence of the digital economy and innovation in the Alpine region. French Tech Alpes is one of the 16 French Tech Capitals in France. The association is supported by a collective of entrepreneurs and a group of stakeholders committed to the development and influence of the digital economy and innovation in the Alpine region. With more than 600 members, French Tech Alpes is an alliance of 5 territories: Annecy, Chambéry, Grenoble, Valence-Romans and the French Genevois. French Alpes participates in the development and influence of the digital economy and young innovative companies: …

Sectors: French Tech

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care

Sectors: Pharmaceutical

[Automatic translation follows] The Alpine Arc Health Technology Cluster MEDICALPS is the Alpine Arc health technology cluster. Since 2000, the association has brought together and represented a network of more than 130 start-ups, SMEs, large groups, research centers, universities and communities from the fields of medical technologies, biotechnologies and e-health. The leadership of MEDICALPS, facilitator and unifier of this community, is largely entrusted to entrepreneurs, with the support of public stakeholders, with the aim of building the medicine of tomorrow. The association's operational programs serve the growth and visibility of the network of industrialists in the field of health technologies …

Our Vision : We have High Standards - We Build Companies - We have Impact Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2). Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

Sectors: Startup accelerator & VC

Filiale du CNRS & de BPI France. 30 ans d'expertise au service de l'innovation et du transfert de technologies. CNRS Innovation, established in 1992, is a French public limited company, now a subsidiary of the CNRS at 90% and 10% Bpifrance Financement. Its mission is to transfer innovative technologies, mainly originating from the CNRS, to the industry. Its action extends from the receipt of projects to the granting of exploitation rights through consulting in Intellectual Property strategies, participation in the filing of patent applications, seeking of industrial partners, negotiating and drafting of exploitation agreements, and management of patent portfolios. CNRS …

Sectors: Research

Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential …

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

[Automatic translation follows] #auvergnerhonealpes Auvergne-Rhône-Alpes is a large region with many assets: - With more than 8 million inhabitants, it is more populated than 13 of the 28 countries of the European Union and ranks 10th most populated region in Europe - Covering nearly 70,000 km2, or 13% of the metropolitan territory, its surface area is equivalent to that of Ireland. - In France, it is the leading industrial and gastronomic region, it ranks first for agricultural production under label (AOP, IGP, etc.) and the number of organic farms. - In Europe: it is the 8th richest region in Europe …

Sectors: National and local authorities

Engineering the extraordinary A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives.

Sectors: Pharmaceutical

Isar Aerospace develops next generation rockets for sustainable access to space Isar Aerospace develops next generation rockets for sustainable access to space for small and medium satellites and satellite constellations.